HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
175850.0,229588,2135-01-09 07:00:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia:
   Presented to hospital with approximately one week of fatigue, anorexia,
   and weight loss. Noted to have initial WBC count of 138k with 84%
   blasts. Was treated initially with leukopheresis and has received total
   of 4 doses of hydroxyurea. Course has been complicated by tumor lysis
   syndrome and disseminated intravascular coagulation.
   - Continue Hydroxyurea 2500 mg [**Hospital1 **] for two additional doses and then
   readdress additional chemotherapy as per bone marrow transplant team
   recommendations
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML. Has received rasburicase. Currently has potassium
   of 3, uric acid of 2.5, phosphate of 11.5, and LDH 2700.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Maintain alkalemia with goal serum bicarb of 30 to 34
   - Maintain adequate urine output for renal protection
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   .
   #. Hypotension:
   Likely caused by hypovolemia as patient has been fluid responsive with
   small boluses on the BMT floor. Additional supporting evidence is that
   patient has low urine output, thirst, and visibly dry mucous membranes.
   Patient is without ECHO evidence of systolic dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia:
   Likely multifactorial with contributions from pneumonia, edema, and
   possible leukemic infiltrate. Patient with cough productive of thick
   yellow sputum at this time. Presented to the ICU on vancomycin and
   cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.7, PLT 11, Fibrinogen 181. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, though no evidence of bleeding at this point.
   - Monitor Q6H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Platelet transfusion now with post-transfusion PLT count
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: ICU for blood pressure monitoring peri-dialysis
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia:
   Presented to hospital with approximately one week of fatigue, anorexia,
   and weight loss. Noted to have initial WBC count of 138k with 84%
   blasts. Was treated initially with leukopheresis and has received total
   of 4 doses of hydroxyurea. Course has been complicated by tumor lysis
   syndrome and disseminated intravascular coagulation.
   - Continue Hydroxyurea 2500 mg [**Hospital1 **] for two additional doses and then
   readdress additional chemotherapy as per bone marrow transplant team
   recommendations
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML. Has received rasburicase. Currently has potassium
   of 3, uric acid of 2.5, phosphate of 11.5, and LDH 2700.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Maintain alkalemia with goal serum bicarb of 30 to 34
   - Maintain adequate urine output for renal protection
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   .
   #. Hypotension:
   Likely caused by hypovolemia as patient has been fluid responsive with
   small boluses on the BMT floor. Additional supporting evidence is that
   patient has low urine output, thirst, and visibly dry mucous membranes.
   Patient is without ECHO evidence of systolic dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia:
   Likely multifactorial with contributions from pneumonia, edema, and
   possible leukemic infiltrate. Patient with cough productive of thick
   yellow sputum at this time. Presented to the ICU on vancomycin and
   cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.7, PLT 11, Fibrinogen 181. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, though no evidence of bleeding at this point.
   - Monitor Q6H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Platelet transfusion now with post-transfusion PLT count
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: ICU for blood pressure monitoring peri-dialysis<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a diagnosis of acute myeloid leukemia (AML), acute renal failure, and disseminated intravascular coagulation (DIC). He is currently admitted to the ICU for close monitoring and treatment.

The patient's laboratory results show worsening tumor lysis syndrome with increasing potassium, uric acid, and phosphate levels. His platelet count is rapidly falling, and he has not required cryoprecipitate or fresh frozen plasma (FFP) at this point. His coagulation studies show elevated FDP, INR, and fibrinogen levels.

The patient's physical examination is limited due to his poor clinical condition. He is not responding to stimuli, and his movement, tone, and skin examination are not assessed. His peripheral vascular examination is also not assessed.

The patient's vital signs show hypotension, tachycardia, and hypoxia. His respiratory support includes oxygen delivery through an aerosol-cool device, and his blood gas analysis shows a pH of 7.29.

The patient's medical history is significant for AML, and his treatment plan includes hydroxyurea, rasburicase, and antibiotics for community-acquired pathogens. His renal function is impaired, and he is receiving dialysis.

Potential medical complications that can arise from the patient's condition include:

1. Tumor lysis syndrome: worsening of laboratory values, including potassium, uric acid, and phosphate levels, which can lead to cardiac arrhythmias, seizures, and acute kidney injury.
2. Disseminated intravascular coagulation: bleeding complications, including petechiae, ecchymoses, and hemorrhages, due to thrombocytopenia and coagulopathy.
3. Acute renal failure: worsening of renal function, leading to increased risk of complications, including hyperkalemia, acidosis, and uremic syndrome.
4. Hypotension: worsening of blood pressure, leading to decreased perfusion of vital organs, including the kidneys, brain, and heart.
5. Hypoxia: worsening of oxygenation, leading to decreased tissue perfusion and increased risk of complications, including acute respiratory distress syndrome (ARDS).
6. Infections: development of infections, including pneumonia, sepsis, and septic shock, due to immunosuppression and poor clinical condition.

The patient's treatment plan should focus on managing his tumor lysis syndrome, disseminated intravascular coagulation, and acute renal failure, while also addressing his hypotension, hypoxia, and potential infections. Close monitoring of his laboratory values, vital signs, and clinical condition is essential to prevent and manage these potential complications."
175850.0,229588,2135-01-09 08:21:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems: overall this am feels well, no CP, SOB, abd pain,
   N/V.  still feels that hands are swollen
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
   10
        [image002.jpg]
   N44, Band2, lymph8, blast42
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 6 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team
   recommendations
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML but improved since dialysis. Has received
   rasburicase. Currently has potassium of 4.2, uric acid of 1.0,
   phosphate of 5.2, and LDH 2565.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Maintain alkalemia with goal serum bicarb of 30 to 34: give bicarb
   now for bicarb of 29
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   .
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor. Additional supporting
   evidence is that patient has low urine output, thirst, and visibly dry
   mucous membranes. Patient is without ECHO evidence of systolic
   dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time. Presented to the ICU on vancomycin
   and cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H (D1:[**1-8**]) for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.5, PLT 31, Fibrinogen 280. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, and has been transfused X1 without evidence of
   bleeding
   - Monitor Q6H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: ICU for blood pressure monitoring peri-dialysis
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems: overall this am feels well, no CP, SOB, abd pain,
   N/V.  still feels that hands are swollen
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
   10
        [image002.jpg]
   N44, Band2, lymph8, blast42
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 6 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team
   recommendations
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML but improved since dialysis. Has received
   rasburicase. Currently has potassium of 4.2, uric acid of 1.0,
   phosphate of 5.2, and LDH 2565.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Maintain alkalemia with goal serum bicarb of 30 to 34: give bicarb
   now for bicarb of 29
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   .
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor. Additional supporting
   evidence is that patient has low urine output, thirst, and visibly dry
   mucous membranes. Patient is without ECHO evidence of systolic
   dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time. Presented to the ICU on vancomycin
   and cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H (D1:[**1-8**]) for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.5, PLT 31, Fibrinogen 280. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, and has been transfused X1 without evidence of
   bleeding
   - Monitor Q6H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: ICU for blood pressure monitoring peri-dialysis<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male admitted with acute myeloid leukemia (AML). He has been treated with leukopheresis and hydroxyurea, but his course has been complicated by tumor lysis syndrome and disseminated intravascular coagulation (DIC). The patient is currently in the ICU for close monitoring and treatment of his condition.

Key findings:

* The patient's WBC count has decreased from 137k to 21.9k, with a significant decrease in blasts.
* The patient has developed tumor lysis syndrome, which has been worsening since initiation of treatment but has improved since dialysis.
* The patient has DIC, with elevated FDP, INR, and decreased fibrinogen levels.
* The patient has acute renal failure, with a creatinine level of 1.4 mg/dL and a urine output of 30-130 cc/hr.
* The patient has mild repletion of K and Mg, and calcium levels are stable.

Potential medical complications:

* Tumor lysis syndrome: The patient's laboratory values indicate worsening tumor lysis syndrome, which can lead to electrolyte imbalances, acidosis, and renal failure.
* Disseminated intravascular coagulation: The patient's DIC can lead to bleeding complications, such as petechiae, ecchymoses, and bleeding from the gastrointestinal tract.
* Acute renal failure: The patient's creatinine level is elevated, and his urine output is decreased, which can lead to electrolyte imbalances, acidosis, and uremic syndrome.
* Hypotension: The patient's blood pressure is low, which can lead to decreased perfusion of vital organs, including the kidneys, heart, and brain.
* Hypoxia: The patient's SpO2 is 100%, but his respiratory status is compromised, which can lead to respiratory failure and hypoxemic respiratory failure.
* Leukemic infiltrate: The patient's leukemia can lead to leukemic infiltrate of organs, including the lungs, liver, and spleen, which can cause respiratory failure, liver dysfunction, and splenic rupture.

Recommendations:

* Continue treatment of AML with hydroxyurea and rasburicase.
* Monitor the patient's laboratory values closely for signs of worsening tumor lysis syndrome or DIC.
* Continue dialysis to manage the patient's acute renal failure.
* Monitor the patient's blood pressure closely and provide fluid boluses as needed to support blood pressure.
* Consider adding antibiotics for community-acquired pathogens to the patient's treatment regimen.
* Monitor the patient's respiratory status closely and provide respiratory support as needed.
* Consider adding levofloxacin to the patient's treatment regimen for coverage of community-acquired pathogens."
175850.0,229588,2135-01-09 08:21:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems: overall this am feels well, no CP, SOB, abd pain,
   N/V.  still feels that hands are swollen
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
   10
        [image002.jpg]
   N44, Band2, lymph8, blast42
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team
   recommendations- will likely have 2 additional doses ordered beyond the
   single dose already ordered for today and then possibly Gemcitabine
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML but improved since dialysis. Has received
   rasburicase. Currently has potassium of 4.2, uric acid of 1.0,
   phosphate of 5.2, and LDH 2565.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Plan was serum bicarb of 20-34 in order to excrete UA, but as UA
   decreased, ? if need to still give bicarb.  Will ask renal.
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor. Additional supporting
   evidence is that patient has low urine output, thirst, and visibly dry
   mucous membranes. Patient is without ECHO evidence of systolic
   dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time. Presented to the ICU on vancomycin
   and cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H (D1:[**1-8**]) for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.5, PLT 31, Fibrinogen 280. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, and has been transfused X1 without evidence of
   bleeding
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -PPI
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: c/o if patient can come off of CVVH, will discuss with
   renal
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems: overall this am feels well, no CP, SOB, abd pain,
   N/V.  still feels that hands are swollen
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
   10
        [image002.jpg]
   N44, Band2, lymph8, blast42
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team
   recommendations- will likely have 2 additional doses ordered beyond the
   single dose already ordered for today and then possibly Gemcitabine
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML but improved since dialysis. Has received
   rasburicase. Currently has potassium of 4.2, uric acid of 1.0,
   phosphate of 5.2, and LDH 2565.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Plan was serum bicarb of 20-34 in order to excrete UA, but as UA
   decreased, ? if need to still give bicarb.  Will ask renal.
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor. Additional supporting
   evidence is that patient has low urine output, thirst, and visibly dry
   mucous membranes. Patient is without ECHO evidence of systolic
   dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time. Presented to the ICU on vancomycin
   and cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H (D1:[**1-8**]) for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.5, PLT 31, Fibrinogen 280. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, and has been transfused X1 without evidence of
   bleeding
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -PPI
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: c/o if patient can come off of CVVH, will discuss with
   renal<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a diagnosis of acute myeloid leukemia (AML) who has been admitted to the ICU for management of complications.

The patient's 24-hour events include the initiation of a pheresis catheter, which resulted in an increase in platelet count from 11 to 53 after platelet transfusion. The patient also received treatment for disseminated intravascular coagulation (DIC) and tumor lysis syndrome (TLS).

The patient's current vital signs are:

* Temperature: 36.7°C (98°F)
* Heart rate: 72 beats per minute (bpm)
* Blood pressure: 104/52 mmHg
* Respiratory rate: 18 breaths per minute (bpm)
* Oxygen saturation: 100%
* Heart rhythm: Sinus rhythm

The patient's physical examination is notable for:

* General: NAD (normal appearance and demeanor)
* Cardiovascular: Regular rhythm, no murmurs or gallop
* Pulmonary: Clear to auscultation bilaterally
* Abdomen: Soft, non-tender
* Extremities: No edema

The patient's laboratory results are:

* Complete Blood Count (CBC): WBC 21.9, Hct 25.9, Plt 53
* Blood chemistry: Sodium 140 mEq/L, Potassium 4.2 mEq/L, Creatinine 1.4 mg/dL, Glucose 153 mg/dL
* Coagulation studies: PT 16.9 seconds, PTT 34.0 seconds, INR 1.5
* Liver function tests: ALT 152 IU/L, AST 126 IU/L, Alk Phos 116 IU/L, T Bili 0.6 mg/dL
* Kidney function tests: Creatinine 1.4 mg/dL, BUN 24.0 mg/dL

The patient's diagnosis and treatment plan include:

* Leukemia, acute (AML): The patient is being treated with hydroxyurea and will likely receive additional chemotherapy as per bone marrow transplant team recommendations.
* Tumor lysis syndrome: The patient has received rasburicase and will continue to receive aluminum hydroxide and allopurinol to control phosphate and uric acid levels.
* Disseminated intravascular coagulation: The patient is being monitored closely for signs of bleeding and will receive cryoprecipitate and FFP if necessary.
* Hypotension: The patient is being treated with fluid boluses and will be monitored closely during dialysis.
* Hypoxia: The patient is being treated with antibiotics and will have sputum sent for gram stain and culture.
* Renal failure: The patient is being managed with CVVH and will be discussed with renal.

Potential medical complications that can arise include:

* Bleeding due to DIC
* Renal failure due to CVVH and underlying AML
* Infection due to pneumonia and potential sepsis
* Cardiac complications due to hypotension and underlying AML
* Neurological complications due to hypoxia and potential leukemic infiltrate

The patient's family has been informed of his condition and treatment plan, and the patient has been designated as full code, meaning he will not receive long-term life support."
175850.0,229588,2135-01-10 06:58:00,Physician ,Physician Resident Progress Note,"TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH, recommended
   alkalinizing urine to bicarb of 28-34
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime, and levofloxacin (d1 [**1-8**])
 have
   confirmed levels but will need to follow-up vanc level at 6pm today.
   Will treat for 8 day course.
   #. Disseminated intravascular coagulation: Currently fibrinogen, coags,
   FDP stable.  Patient has not required cryoprecipitate or FFP at this
   point. Platelet count is rapidly falling, and has been transfused X1
   without evidence of bleeding but may need another transfusion today
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH, recommended
   alkalinizing urine to bicarb of 28-34
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime, and levofloxacin (d1 [**1-8**])
 have
   confirmed levels but will need to follow-up vanc level at 6pm today.
   Will treat for 8 day course.
   #. Disseminated intravascular coagulation: Currently fibrinogen, coags,
   FDP stable.  Patient has not required cryoprecipitate or FFP at this
   point. Platelet count is rapidly falling, and has been transfused X1
   without evidence of bleeding but may need another transfusion today
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a chief complaint of acute myeloid leukemia (AML). He was admitted with an initial white blood cell count of 138,000 with 84% blasts and has received a total of 4 doses of hydroxyurea. The patient's course has been complicated by tumor lysis syndrome (TLS) and disseminated intravascular coagulation (DIC).

The patient's vital signs are stable, with a temperature of 36.6°C (97.9°F), heart rate of 76 beats per minute, blood pressure of 118/58 mmHg, and oxygen saturation of 92%. His respiratory support includes nasal cannula oxygen delivery.

The patient's physical examination is significant for bilateral chest tube drainage, soft and tender abdomen, and no evidence of edema or bleeding.

Laboratory results show a white blood cell count of 21.9, hemoglobin of 7.4 g/dL, and platelet count of 53. His blood chemistry is significant for elevated lactate dehydrogenase (LDH) of 1581 IU/L, alkaline phosphatase (ALT) of 100, and aspartate aminotransferase (AST) of 61.

The patient's assessment and plan include:

* Acute myeloid leukemia: The patient's AML is being treated with hydroxyurea, and he is awaiting further chemotherapy as per the bone marrow transplant team.
* Tumor lysis syndrome: The patient's TLS is being managed with rasburicase, and his laboratory results are stable after stopping continuous venovenous hemofiltration (CVVH).
* Hypotension: The patient's hypotension is likely caused by hypovolemia, and he is being treated with fluid boluses as needed.
* Hypoxia: The patient's hypoxia is likely multifactorial and is being treated with antibiotics and oxygen therapy.
* Disseminated intravascular coagulation: The patient's DIC is being managed with platelet transfusions and close monitoring of his coagulation parameters.

Potential medical complications that may arise include:

* Tumor lysis syndrome: The patient's TLS may continue to worsen, leading to life-threatening complications such as acute kidney injury, cardiac arrhythmias, and seizures.
* Disseminated intravascular coagulation: The patient's DIC may progress, leading to bleeding complications, including intracranial hemorrhage, gastrointestinal bleeding, and pulmonary bleeding.
* Hypotension: The patient's hypotension may worsen, leading to organ dysfunction, including acute kidney injury, acute respiratory distress syndrome, and cardiac arrest.
* Hypoxia: The patient's hypoxia may worsen, leading to respiratory failure, cardiac arrest, and death.
* Infection: The patient is at risk of developing infections, including pneumonia, sepsis, and bacteremia, which may worsen his underlying condition and lead to further complications.

It is essential to closely monitor the patient's condition and adjust his treatment plan accordingly to prevent and manage these potential complications."
175850.0,229588,2135-01-10 06:58:00,Physician ,Physician Resident Progress Note,"TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime, and levofloxacin (d1 [**1-8**])
 have
   confirmed levels but will need to follow-up vanc level at 6pm today.
   Will treat for 8 day course.
   #. Disseminated intravascular coagulation: Currently fibrinogen, coags,
   FDP stable.  Patient has not required cryoprecipitate or FFP at this
   point. Platelet count is rapidly falling, and has been transfused X1
   without evidence of bleeding but may need another transfusion today
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime, and levofloxacin (d1 [**1-8**])
 have
   confirmed levels but will need to follow-up vanc level at 6pm today.
   Will treat for 8 day course.
   #. Disseminated intravascular coagulation: Currently fibrinogen, coags,
   FDP stable.  Patient has not required cryoprecipitate or FFP at this
   point. Platelet count is rapidly falling, and has been transfused X1
   without evidence of bleeding but may need another transfusion today
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following information is summarized:

The patient is an 80-year-old male with no significant past medical history, admitted with acute myeloid leukemia (AML). He presented with fatigue, anorexia, and weight loss, and was initially treated with leukopheresis and hydroxyurea. His course has been complicated by tumor lysis syndrome, disseminated intravascular coagulation (DIC), and hypotension.

The patient's current vital signs are:

* Temperature: 36.6°C (97.9°F)
* Heart rate: 76 beats per minute (bpm)
* Blood pressure: 118/58 mmHg
* Respiratory rate: 20 breaths per minute (bpm)
* SpO2: 92%
* Heart rhythm: Sinus rhythm

The patient's laboratory results are:

* White blood cell count (WBC): 21.9 x 10^9/L
* Hematocrit (Hct): 21.8%
* Platelet count: 53 x 10^9/L
* Creatinine: 1.4 mg/dL
* Glucose: 153 mg/dL
* Lactic acid: 1.2 mmol/L
* Fibrinogen: 286 mg/dL
* International normalized ratio (INR): 1.3
* Partial thromboplastin time (PTT): 35.0 seconds
* Activated partial thromboplastin time (APTT): 100 seconds
* Lipase: 100 IU/L
* Alanine aminotransferase (ALT): 100 IU/L
* Aspartate aminotransferase (AST): 61 IU/L
* Lactate dehydrogenase (LDH): 1581 IU/L

The patient is receiving the following treatments:

* Hydroxyurea: 2500mg
* Vancomycin: 1g IV every 12 hours
* Cefepime: 2g IV every 8 hours
* Levofloxacin: 500mg IV every 24 hours
* Rasburicase: 20mg IV every 24 hours
* Aluminum hydroxide: 100cc/hr 150 mEq Sodium Bicarb/1000ml D5W
* Allopurinol: 300mg IV every 12 hours

Potential medical complications that may arise include:

1. Tumor lysis syndrome: The patient's laboratory results show worsening tumor lysis syndrome, which may lead to further complications such as hyperkalemia, hyperphosphatemia, and hypocalcemia.
2. Disseminated intravascular coagulation (DIC): The patient's laboratory results show evidence of DIC, which may lead to further complications such as bleeding, thrombosis, and organ failure.
3. Hypotension: The patient's blood pressure is low, which may lead to further complications such as organ failure, shock, and death.
4. Hypoxia: The patient's oxygen saturation is low, which may lead to further complications such as respiratory failure, cardiac arrest, and death.
5. Infection: The patient's respiratory symptoms and laboratory results may indicate the presence of an infection, which may lead to further complications such as sepsis, organ failure, and death.

The patient's care plan includes:

1. Continued treatment of AML with hydroxyurea, vancomycin, cefepime, and levofloxacin.
2. Monitoring of the patient's laboratory results, including WBC count, Hct, platelet count, creatinine, and glucose levels.
3. Management of tumor lysis syndrome with rasburicase and alkalinization of the urine.
4. Management of DIC with transfusion of platelets and cryoprecipitate as needed.
5. Management of hypotension with fluid boluses and vasopressors as needed.
6. Management of hypoxia with oxygen therapy and treatment of underlying respiratory symptoms.
7. Monitoring of the patient's respiratory status, including oxygen saturation and respiratory rate.
8. Monitoring of the patient's cardiovascular status, including blood pressure and heart rate.
9. Monitoring of the patient's neurological status, including level of consciousness and cranial nerve function.
10. Communication with the patient's family and healthcare providers regarding the patient's condition and treatment plan."
175850.0,229588,2135-01-10 06:58:00,Physician ,Physician Resident Progress Note,"TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH, recommended
   alkalinizing urine to bicarb of 28-34
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: RRR nl s1/s2 no mrg
   Pulm: CTAB
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has hydroxyurea. Course has been complicated by tumor lysis
   syndrome and disseminated intravascular coagulation.
   - continue decreased dose of hydroxyurea today and tomorrow
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W in order to prevent uric acid crystal
   accumulation
   - Maintain adequate urine output for renal protection
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid levels
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime (d1 [**1-7**]), and levofloxacin (d1 [**1-8**])
 have confirmed levels but will need to follow-up vanc level at 6pm
   today.  Will treat for 8 day course.
   #. Disseminated intravascular coagulation/Anemia: Currently fibrinogen,
   coags, FDP stable.  Patient has not required cryoprecipitate or FFP at
   this point.  Platelet count dropping but no signs of bleeding.
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am and recheck
   post-transfusion Hct
   - Feel that anemia is likely secondary to hydroxyurea administration,
   but will add on hapto to am labs to evaluate for hemolysis
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines: 20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH, recommended
   alkalinizing urine to bicarb of 28-34
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: RRR nl s1/s2 no mrg
   Pulm: CTAB
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has hydroxyurea. Course has been complicated by tumor lysis
   syndrome and disseminated intravascular coagulation.
   - continue decreased dose of hydroxyurea today and tomorrow
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W in order to prevent uric acid crystal
   accumulation
   - Maintain adequate urine output for renal protection
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid levels
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime (d1 [**1-7**]), and levofloxacin (d1 [**1-8**])
 have confirmed levels but will need to follow-up vanc level at 6pm
   today.  Will treat for 8 day course.
   #. Disseminated intravascular coagulation/Anemia: Currently fibrinogen,
   coags, FDP stable.  Patient has not required cryoprecipitate or FFP at
   this point.  Platelet count dropping but no signs of bleeding.
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am and recheck
   post-transfusion Hct
   - Feel that anemia is likely secondary to hydroxyurea administration,
   but will add on hapto to am labs to evaluate for hemolysis
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines: 20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male admitted with acute myeloid leukemia (AML). He presented with fatigue, anorexia, and weight loss, and was initially treated with leukopheresis and hydroxyurea. His course has been complicated by tumor lysis syndrome and disseminated intravascular coagulation (DIC). The patient's current condition includes:

* Worsening tumor lysis syndrome, which has improved since stopping continuous venovenous hemofiltration (CVVH)
* Hypotension, likely caused by hypovolemia, which has been treated with fluid boluses
* Hypoxia, likely multifactorial, which is being treated with antibiotics and oxygen therapy
* Disseminated intravascular coagulation, which is being monitored with laboratory tests and treated with blood products as needed
* Anemia, likely secondary to hydroxyurea administration, which is being treated with blood transfusions
* Decreased platelet count, which is being monitored and treated with blood products as needed

Potential Medical Complications:

1. Tumor lysis syndrome: Continued worsening of tumor lysis syndrome could lead to severe electrolyte imbalances, renal failure, and cardiac arrhythmias.
2. Disseminated intravascular coagulation: Continued progression of DIC could lead to bleeding complications, organ failure, and death.
3. Hypotension: Failure to treat hypotension could lead to organ failure, particularly in the kidneys and liver.
4. Hypoxia: Failure to treat hypoxia could lead to respiratory failure, cardiac arrest, and death.
5. Anemia: Failure to treat anemia could lead to fatigue, decreased oxygen delivery to tissues, and decreased cardiac output.
6. Decreased platelet count: Failure to treat thrombocytopenia could lead to bleeding complications, particularly in the brain, spinal cord, and gastrointestinal tract.
7. Infection: The patient's immunocompromised state and presence of central lines and catheters increase the risk of infection, which could lead to sepsis and organ failure.

Recommendations:

1. Continue to monitor the patient's laboratory values, particularly electrolyte levels, creatinine, and blood counts.
2. Continue to treat the patient's tumor lysis syndrome, DIC, and hypoxia with appropriate medications and therapies.
3. Monitor the patient's blood pressure and volume status, and treat hypotension with fluid boluses and vasopressors as needed.
4. Continue to transfuse blood products as needed to treat anemia and thrombocytopenia.
5. Monitor the patient's respiratory status and treat hypoxia with oxygen therapy and mechanical ventilation as needed.
6. Consider adjusting the patient's antibiotic regimen based on the results of sputum cultures and blood cultures.
7. Continue to monitor the patient's nutritional status and provide regular renal diet as needed.
8. Consider adding hapto to the patient's medications to evaluate for hemolysis."
175850.0,229588,2135-01-10 10:28:00,Physician ,Physician Attending Progress Note,"Chief Complaint: DIC, TLS, arf
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   80 M with newly diagnosed AML complicated by TLS and DIC, transferred
   to the ICU for hemodialysis for hyperphosphatemia.
   24 Hour Events:
   CVVH stopped yesterday
   transfused 1 unit prbc this morning for hct 21
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-10**] 08:38 AM
   Infusions:
   Other ICU medications:
   Other medications:
   per [**Month (only) **] (reviewed)
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 10:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.3
C (97.3
   HR: 73 (65 - 92) bpm
   BP: 104/48(63) {92/45(59) - 120/93(97)} mmHg
   RR: 18 (16 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
           Total In:
                                                                  4,504 mL
                                                                  1,302 mL
   PO:
                                                                  1,800 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  2,704 mL
                                                                    527 mL
   Blood products:
   295 mL
   Total out:
                                                                  2,899 mL
                                                                  1,620 mL
   Urine:
                                                                  2,215 mL
                                                                  1,620 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -318 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///29/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: No(t) Endotracheal tube
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Warm
   Neurologic: Attentive and appropriate
   Labs / Radiology
   7.4 g/dL
   17 K/uL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   Microbiology: [**1-7**] and 19 bl pending
   urine [**1-8**]-neg
   hcv hbv pending
   Assessment and Plan
   80 M with newly diagnosed AML complicated by TLS and DIC, transferred
   to the ICU for hemodialysis for hyperphosphatemia.
   Primary issues include:
   # Tumor Lysis Syndrome
   - labs much improved
   -CVVH stopped yesterday
   -continue alkalinization of urine, follow uric acid level
   - q8 hr tumor lysis labs
   --monitor urine outpt and renal fx closely
   # AML
   -Receiving hydroxyurea,
   -BMT regarding plan for additional chemotherapy
   # DIC:
   --follow serial labs
   --transfuse for platelets <20K,
         INR > 2, ffp
        fibrinogen <100, cryoprecipitate
   --Given decline in hct, suspect hydroxyurea effect
   --Monitor for hemolysis
   # Hypoxemia: ? secondary to pneumonia v. edema v. leukemic effect,
   improved
   - continue day [**4-28**] empiric vanc/cefepime/l day [**3-28**] levofloxacin, given
   functional neurtopenia
   --follow pending cx data
    Remainder as per resident note
   ICU Care
   Nutrition: renal diet
   Glycemic Control:
   Lines:
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   20 Gauge - [**2135-1-10**] 08:43 AM
   Prophylaxis:
   DVT:
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition : d/w bmt regarding floor transfer
   Total time spent: 35 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: DIC, TLS, arf
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   80 M with newly diagnosed AML complicated by TLS and DIC, transferred
   to the ICU for hemodialysis for hyperphosphatemia.
   24 Hour Events:
   CVVH stopped yesterday
   transfused 1 unit prbc this morning for hct 21
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-10**] 08:38 AM
   Infusions:
   Other ICU medications:
   Other medications:
   per [**Month (only) **] (reviewed)
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 10:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.3
C (97.3
   HR: 73 (65 - 92) bpm
   BP: 104/48(63) {92/45(59) - 120/93(97)} mmHg
   RR: 18 (16 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
           Total In:
                                                                  4,504 mL
                                                                  1,302 mL
   PO:
                                                                  1,800 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  2,704 mL
                                                                    527 mL
   Blood products:
   295 mL
   Total out:
                                                                  2,899 mL
                                                                  1,620 mL
   Urine:
                                                                  2,215 mL
                                                                  1,620 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -318 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///29/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: No(t) Endotracheal tube
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Warm
   Neurologic: Attentive and appropriate
   Labs / Radiology
   7.4 g/dL
   17 K/uL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   Microbiology: [**1-7**] and 19 bl pending
   urine [**1-8**]-neg
   hcv hbv pending
   Assessment and Plan
   80 M with newly diagnosed AML complicated by TLS and DIC, transferred
   to the ICU for hemodialysis for hyperphosphatemia.
   Primary issues include:
   # Tumor Lysis Syndrome
   - labs much improved
   -CVVH stopped yesterday
   -continue alkalinization of urine, follow uric acid level
   - q8 hr tumor lysis labs
   --monitor urine outpt and renal fx closely
   # AML
   -Receiving hydroxyurea,
   -BMT regarding plan for additional chemotherapy
   # DIC:
   --follow serial labs
   --transfuse for platelets <20K,
         INR > 2, ffp
        fibrinogen <100, cryoprecipitate
   --Given decline in hct, suspect hydroxyurea effect
   --Monitor for hemolysis
   # Hypoxemia: ? secondary to pneumonia v. edema v. leukemic effect,
   improved
   - continue day [**4-28**] empiric vanc/cefepime/l day [**3-28**] levofloxacin, given
   functional neurtopenia
   --follow pending cx data
    Remainder as per resident note
   ICU Care
   Nutrition: renal diet
   Glycemic Control:
   Lines:
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   20 Gauge - [**2135-1-10**] 08:43 AM
   Prophylaxis:
   DVT:
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition : d/w bmt regarding floor transfer
   Total time spent: 35 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with newly diagnosed acute myeloid leukemia (AML) complicated by tumor lysis syndrome (TLS) and disseminated intravascular coagulation (DIC). He was transferred to the ICU for hemodialysis due to hyperphosphatemia.

The patient's current vital signs are:

* Temperature: 36.3°C (97.3°F)
* Heart rate: 73 bpm (normal range 65-92 bpm)
* Blood pressure: 104/48 mmHg (normal range 92-120/45-93 mmHg)
* Respiratory rate: 18 breaths per minute (normal range 16-24 breaths per minute)
* Oxygen saturation: 97% on nasal cannula

The patient's physical examination is notable for:

* Right and left radial pulses present
* Right and left digital pulses present
* Soft, non-tender abdomen with bowel sounds present
* No acute distress or respiratory distress
* Warm skin
* Attentive and appropriate neurologic examination

Laboratory results show:

* White blood cell count: 21.9 x 10^9/L
* Hemoglobin: 7.4 g/dL
* Platelet count: 53 x 10^9/L
* Creatinine: 1.4 mg/dL
* Uric acid: 114 mg/dL
* Calcium: 7.5 mg/dL
* Magnesium: 1.6 mg/dL
* Phosphorus: 4.7 mg/dL
* Lactic acid: 1.2 mmol/L
* Albumin: 2.4 g/dL
* LDH: 1581 IU/L

The patient's medical issues include:

* Tumor Lysis Syndrome: Labs have improved, but the patient will require continued alkalinization of urine and monitoring of uric acid levels. Q8-hour tumor lysis labs will be performed, and urine output and renal function will be closely monitored.
* AML: The patient is receiving hydroxyurea, and a plan for additional chemotherapy is being developed. He will require close monitoring for hemolysis.
* DIC: The patient will require serial lab monitoring, and transfusions will be given for platelets <20K, INR >2, and fibrinogen <100. Cryoprecipitate will also be administered as needed.
* Hypoxemia: The patient's hypoxemia may be secondary to pneumonia, edema, or leukemic effect. He will require continued empiric antibiotics and close monitoring of pending CXR data.

The patient's plan includes:

* Continued hemodialysis for hyperphosphatemia
* Monitoring of tumor lysis syndrome and DIC
* Development of a plan for additional chemotherapy for AML
* Close monitoring for hemolysis and hypoxemia
* Continued empiric antibiotics for pneumonia
* Serial lab monitoring and transfusions as needed

Potential medical complications that can arise include:

* Further deterioration of renal function due to TLS or DIC
* Development of bleeding or thrombotic complications due to DIC
* Hemolysis or anemia due to AML or hydroxyurea
* Respiratory failure due to pneumonia, edema, or leukemic effect
* Infection due to neutropenia or other immunocompromised states
* Cardiovascular instability due to hypotension or hypertension
* Gastrointestinal bleeding or obstruction due to tumor or therapy-related effects"
175850.0,229588,2135-01-10 10:28:00,Physician ,Physician Attending Progress Note,"Chief Complaint: DIC, tumor lysis, arf
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   CVVH stopped yesterday
   transfused 1 unit prbc this morning for hct 21
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-10**] 08:38 AM
   Infusions:
   Other ICU medications:
   Other medications:
   per [**Month (only) **] (reviewed)
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 10:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.3
C (97.3
   HR: 73 (65 - 92) bpm
   BP: 104/48(63) {92/45(59) - 120/93(97)} mmHg
   RR: 18 (16 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
           Total In:
                                                                  4,504 mL
                                                                  1,302 mL
   PO:
                                                                  1,800 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  2,704 mL
                                                                    527 mL
   Blood products:
   295 mL
   Total out:
                                                                  2,899 mL
                                                                  1,620 mL
   Urine:
                                                                  2,215 mL
                                                                  1,620 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -318 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///29/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: No(t) Endotracheal tube
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Musculoskeletal: No(t) Muscle wasting, No(t) Unable to stand
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, No(t) Sedated, Tone: Not assessed
   Labs / Radiology
   7.4 g/dL
   17 K/uL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   Microbiology: [**1-7**] and 19 bl pending
   urine [**1-8**]-neg
   hcv hbv pending
   Assessment and Plan
   # Tumor Lysis Syndrome
   - labs much improved and P04 down post-HD
   --CVVH stopped yesterday
   -continue alkalinization of urine given following uric acid,  follow
   uric acid level
   - follow q8 hr tumor lysis labs
   --Follow urine outpt and renal fx closely
   # AML
   -Receiving hydroxyurea,
   -BMT regarding plan for further chemotherapy
   # DIC: serial labs
   --transfuse for platelets <20K
   --if INR > 2, ffp
   --if fibrinogen <100, will transfuse cryoprecipitate
   --Given falling hct as well, suspect hydroxyurea effect
   --Monitor for hemolysis, check habtoglobin
   # Hypoxemia: ? secondary to pneumonia v. edema v. leukemic effect
   - continue day [**4-28**] empiric vanc/cefepime/l day [**3-28**] levofloxacin, given
   functional neurtopenia
   --follow pending cx data
    # Hypotension
   - resolved, likely hypovolemic, fluids as needed
   ICU Care
   Nutrition: renal diet
   Glycemic Control:
   Lines:
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   20 Gauge - [**2135-1-10**] 08:43 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition : d/w bmt regarding floor transfer
   Total time spent: 35 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: DIC, tumor lysis, arf
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   CVVH stopped yesterday
   transfused 1 unit prbc this morning for hct 21
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-10**] 08:38 AM
   Infusions:
   Other ICU medications:
   Other medications:
   per [**Month (only) **] (reviewed)
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 10:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.3
C (97.3
   HR: 73 (65 - 92) bpm
   BP: 104/48(63) {92/45(59) - 120/93(97)} mmHg
   RR: 18 (16 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
           Total In:
                                                                  4,504 mL
                                                                  1,302 mL
   PO:
                                                                  1,800 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  2,704 mL
                                                                    527 mL
   Blood products:
   295 mL
   Total out:
                                                                  2,899 mL
                                                                  1,620 mL
   Urine:
                                                                  2,215 mL
                                                                  1,620 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -318 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///29/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: No(t) Endotracheal tube
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Musculoskeletal: No(t) Muscle wasting, No(t) Unable to stand
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, No(t) Sedated, Tone: Not assessed
   Labs / Radiology
   7.4 g/dL
   17 K/uL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   Microbiology: [**1-7**] and 19 bl pending
   urine [**1-8**]-neg
   hcv hbv pending
   Assessment and Plan
   # Tumor Lysis Syndrome
   - labs much improved and P04 down post-HD
   --CVVH stopped yesterday
   -continue alkalinization of urine given following uric acid,  follow
   uric acid level
   - follow q8 hr tumor lysis labs
   --Follow urine outpt and renal fx closely
   # AML
   -Receiving hydroxyurea,
   -BMT regarding plan for further chemotherapy
   # DIC: serial labs
   --transfuse for platelets <20K
   --if INR > 2, ffp
   --if fibrinogen <100, will transfuse cryoprecipitate
   --Given falling hct as well, suspect hydroxyurea effect
   --Monitor for hemolysis, check habtoglobin
   # Hypoxemia: ? secondary to pneumonia v. edema v. leukemic effect
   - continue day [**4-28**] empiric vanc/cefepime/l day [**3-28**] levofloxacin, given
   functional neurtopenia
   --follow pending cx data
    # Hypotension
   - resolved, likely hypovolemic, fluids as needed
   ICU Care
   Nutrition: renal diet
   Glycemic Control:
   Lines:
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   20 Gauge - [**2135-1-10**] 08:43 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition : d/w bmt regarding floor transfer
   Total time spent: 35 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 24-hour-old ICU admission with a chief complaint of disseminated intravascular coagulation (DIC), tumor lysis syndrome, and acute respiratory failure (ARF). The patient's vital signs are stable, with a temperature of 36.3°C, heart rate of 73 bpm, and blood pressure of 104/48 mmHg. The patient's respiratory support includes nasal cannula oxygen and is stable, with an SpO2 of 97%.

The patient's laboratory results show improvement in tumor lysis syndrome, with a decreasing phosphorus level post-hemodialysis (HD). The patient is receiving alkalinization of urine to manage uric acid levels. The patient's platelet count is low, and they are receiving platelet transfusions. The patient's international normalized ratio (INR) is elevated, and they are receiving fresh frozen plasma (FFP) and cryoprecipitate as needed.

The patient's bleeding diathesis is likely related to DIC, and they are receiving transfusions for platelets <20K. The patient's hemoglobin level is decreasing, and they are at risk for hemolysis. The patient's lactate level is elevated, and they are at risk for metabolic acidosis.

The patient's respiratory status is stable, with a normal ABG result. The patient's physical examination is notable for right lower extremity edema, which is improving. The patient's neurological examination is normal, with no signs of sedation or muscle wasting.

The patient's medical plan includes continued alkalinization of urine, close monitoring of tumor lysis syndrome labs, and serial platelet transfusions. The patient is also receiving hydroxyurea for acute myeloid leukemia (AML) and is awaiting further chemotherapy. The patient's bleeding diathesis is being managed with FFP and cryoprecipitate as needed.

Potential medical complications that can arise include:

1. Further deterioration of DIC, leading to bleeding or thrombosis.
2. Development of tumor lysis syndrome, leading to hyperkalemia, hyperphosphatemia, and hypocalcemia.
3. Progression of AML, leading to worsening bone marrow function and increased risk of bleeding.
4. Development of respiratory failure, requiring mechanical ventilation.
5. Development of sepsis, leading to multi-organ failure.
6. Development of hypotension, requiring vasopressor support.
7. Development of metabolic acidosis, requiring treatment with sodium bicarbonate.
8. Development of hemolysis, requiring transfusions and supportive care.

In summary, the patient is a critically ill individual with multiple complex medical conditions, requiring close monitoring and management."
